Unknown

Dataset Information

0

SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin.

ABSTRACT:

SUBMITTER: Volk A 

PROVIDER: S-EPMC8628143 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma.
| S-EPMC7946899 | biostudies-literature
Unknown IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools.
| S-EPMC8726489 | biostudies-literature
Unknown Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma.
| S-EPMC7871744 | biostudies-literature
Unknown Development and characterization of anti-SARS-CoV-2 intravenous immunoglobulin from COVID-19 convalescent plasma.
| S-EPMC9328115 | biostudies-literature
Unknown Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodies.
| S-EPMC8420279 | biostudies-literature
Unknown Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum.
| S-EPMC8043482 | biostudies-literature
Unknown Relationship between Anti-Spike Protein Antibody Titers and SARS-CoV-2 In Vitro Virus Neutralization in Convalescent Plasma.
| S-EPMC7302218 | biostudies-literature
Unknown Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization.
| S-EPMC7685744 | biostudies-literature
Unknown Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore.
| S-EPMC8546091 | biostudies-literature
Unknown Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum.
| S-EPMC8390486 | biostudies-literature